Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REFINE: Etanercept dosing in psoriasis
NCT01313221Phase 3Completed
- Sponsor
- Amgen
- Start
- Apr 2011
- Primary completion
- Dec 2012
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of etanercept in plaque psoriasis, sponsored by Amgen. Started Apr 2011; status: completed.
02
Drugs
etanercept
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01313221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01313221.